Management of Chronic Total Occlusion of Coronary Artery
- PMID: 34025095
- PMCID: PMC8128489
- DOI: 10.1055/s-0040-1721478
Management of Chronic Total Occlusion of Coronary Artery
Abstract
Chronic total occlusion (CTO) of a coronary artery is typically defined as a completely occluded artery without any antegrade flow and a duration of at least 3 months. We reviewed the current literature describing the optimal management of CTO including the role of revascularization and choice of modality, i.e., percutaneous coronary intervention (PCI) or coronary artery bypass graft surgery. Databases (PubMed, the Cochrane Library, Embase, EBSCO, Web of Science, and CINAHL) were searched and relevant studies of patients with CTO were selected for review. The prevalence of coronary artery CTOs is approximately 25% among patients undergoing coronary angiography for angina. Available data suggests that PCI of CTO can be a technically complex procedure with relatively lower success rates compared with non-CTO PCI and typically associated with a higher complication rate especially at nonspecialized centers. Furthermore, successful CTO-PCI is associated with symptomatic improvement but does not appear to improve mortality, myocardial infarction, stroke, and repeat revascularization rates. Based on contemporary data, PCI of CTO lesions may be considered in patients with incapacitating angina despite treatment with optimal guideline-directed medical therapy and in whom based on coronary anatomy there is a reasonable chance of technical success with an acceptable risk.
Keywords: chronic total occlusion; complete revascularization; optimal medical therapy; percutaneous coronary intervention; revascularization.
International College of Angiology. This article is published by Thieme.
Conflict of interest statement
Conflict of Interest Authors confirm that they have no conflict of interest.
Similar articles
-
The Role of Percutaneous Coronary Intervention in the Treatment of Chronic Total Occlusions: Rationale and Review of the Literature.Curr Vasc Pharmacol. 2019;17(3):278-290. doi: 10.2174/1570161116666180117100635. Curr Vasc Pharmacol. 2019. PMID: 29345588 Review.
-
Update on the Management of Chronic Total Occlusions in Coronary Artery Disease.Curr Atheroscler Rep. 2017 Apr;19(4):19. doi: 10.1007/s11883-017-0655-0. Curr Atheroscler Rep. 2017. PMID: 28315181 Review.
-
Contemporary Incidence, Management, and Long-Term Outcomes of Percutaneous Coronary Interventions for Chronic Coronary Artery Total Occlusions: Insights From the VA CART Program.JACC Cardiovasc Interv. 2017 May 8;10(9):866-875. doi: 10.1016/j.jcin.2017.02.044. JACC Cardiovasc Interv. 2017. PMID: 28473108
-
The predictors of successful percutaneous coronary intervention in ostial left anterior descending artery chronic total occlusion.Catheter Cardiovasc Interv. 2014 Oct 1;84(4):E30-7. doi: 10.1002/ccd.25514. Epub 2014 May 13. Catheter Cardiovasc Interv. 2014. PMID: 24740864
-
Initial success rate of percutaneous coronary intervention for chronic total occlusion in a native coronary artery is decreased in patients who underwent previous coronary artery bypass graft surgery.JACC Cardiovasc Interv. 2014 Jan;7(1):39-46. doi: 10.1016/j.jcin.2013.08.012. JACC Cardiovasc Interv. 2014. PMID: 24456717
Cited by
-
In Vitro Analysis of the Cytocompatibility of a Novel Porcine Aortic Patch for Vascular Reconstruction.In Vivo. 2022 Jan-Feb;36(1):63-75. doi: 10.21873/invivo.12677. In Vivo. 2022. PMID: 34972701 Free PMC article.
-
The Atherogenic Index of Plasma is a Predictor for Chronic Total Occlusion and Coronary Collateral Circulation Formation in CTOs Patients.Rev Cardiovasc Med. 2023 Oct 23;24(10):305. doi: 10.31083/j.rcm2410305. eCollection 2023 Oct. Rev Cardiovasc Med. 2023. PMID: 39077586 Free PMC article.
-
[Technical armamentarium for chronic total occlusion of coronary vessels].Herz. 2021 Oct;46(5):406-418. doi: 10.1007/s00059-021-05053-y. Epub 2021 Aug 16. Herz. 2021. PMID: 34398249 Review. German.
-
Evaluation of FFR and CPET in patients with de novo coronary chronic total occlusion treated with DCB vs. DES.Front Cardiovasc Med. 2025 Jul 31;12:1584548. doi: 10.3389/fcvm.2025.1584548. eCollection 2025. Front Cardiovasc Med. 2025. PMID: 40822011 Free PMC article.
-
PCI for Chronic Total Occlusions with Distal Diffuse Disease: Stent Alone vs. Stent plus Drug Balloon.Int J Cardiol Heart Vasc. 2025 Aug 2;60:101762. doi: 10.1016/j.ijcha.2025.101762. eCollection 2025 Oct. Int J Cardiol Heart Vasc. 2025. PMID: 40800725 Free PMC article.
References
-
- Agrawal H, Lange R A, Montanez R. The role of percutaneous coronary intervention in the treatment of chronic total occlusions: rationale and review of the literature. Curr Vasc Pharmacol. 2019;17(03):278–290. - PubMed
-
- Fefer P, Knudtson M L, Cheema A N. Current perspectives on coronary chronic total occlusions: the Canadian Multicenter Chronic Total Occlusions Registry. J Am Coll Cardiol. 2012;59(11):991–997. - PubMed
-
- Tsai T T, Stanislawski M A, Shunk K A. Contemporary incidence, management, and long-term outcomes of percutaneous coronary interventions for chronic coronary artery total occlusions: insights from the VA CART program. JACC Cardiovasc Interv. 2017;10(09):866–875. - PubMed
-
- Mukherjee D, Roffi M. Chronic total occlusions in non-infarct-related arteries. Eur Heart J. 2012;33(06):695–697. - PubMed
-
- Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group . Ursoniu S, Mikhailidis D P, Serban M C. The effect of statins on cardiovascular outcomes by smoking status: a systematic review and meta-analysis of randomized controlled trials. Pharmacol Res. 2017;122:105–117. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous